facebook-page-view
Advertisement

compulsorily convertible preference shares

Biocon concludes Viatris' $3 bn acquisition

Healthcare

Biocon concludes Viatris' $3 bn acquisition

Biosimilars manufacturing arm of Biocon Ltd, Biocon Biologics, on Tuesday announced completion of ...

CDPQ becomes 20% equity owner in Edelweiss ARC

Finance

CDPQ becomes 20% equity owner in Edelweiss ARC

CDPQ Private Equity Asia has picked up a 20% equity stake in Edelweiss Asset Reconstruction Company ...